Note: Ingredients listed on restricted chemical lists
EC/CAS
200-661-7/67-63-0
Name of the chemical
Propan-2-ol
Concentration
>90.0-<100.0% 3- >1.0-<2.5%
General Information
Version
18.0
Revision date
2023-02-28
Product name
BETAWIPE VP 04604
1.2.1 Relevant identified uses
An activator -- For use in automotive applications
Manufacturer Name
DuPont Specialty Products GmbH & Co. KG
Emergency telephone
+(44)-870-8200418
Icons in SDS
Company Information
company name
DuPont Specialty Products GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion-EU@dupont.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H225, H317, H319, H336
Hazard statements
Code
Statements
H225
Highly flammable liquid and vapour
H317
May cause an allergic skin reaction
H319
Causes serious eye irritation
H336
May cause drowsiness or dizziness
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
DANGER
Hazard statements
H225 Highly flammable liquid and vapour. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H336 May cause drowsiness or dizziness.
Precautionary statements
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 Keep container tightly closed. P261 Avoid breathing mist or vapours. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P303 + P361 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with + P353 water. P370 + P378 In case of fire: Use dry sand, dry chemical or alcohol-resistant foam to extinguish.
Contains
isopropanol; N-(3-(Trimethoxysilyl) propyl)-1,2-ethanediamine; 3- Mercaptopropyltrimethoxysilane
2.3 Other hazards
Endocrine disrupting properties (human health): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Endocrine disrupting properties (environment): The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.